Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM25347 LCL from B-Lymphocyte

Description:

CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
N-GLYCANASE 1; NGLY1

Affected:

Yes

Sex:

Male

Age:

3 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Biopsy Source Peripheral vein
Cell Type B-Lymphocyte
Tissue Type Blood
Transformant Epstein-Barr Virus
Sample Source LCL from B-Lymphocyte
Race White
Ethnicity Not Hispanic/Latino
Ethnicity German
Country of Origin GERMANY
Family Member 1
Family History N
Relation to Proband proband
Confirmation Molecular characterization before cell line submission to CCR
Species Homo sapiens
Common Name Human
Remarks Clinically affected; diagnosed by geneticist at 2 years of age; onset of symptoms at birth; delivered by Cesarean section at 38 weeks gestation when fetal distress was noted on cardiotocography; intrauterine growth restriction; neonatal jaundice; hypotonia; constipation in infancy; intermittent head flexion at 6 months; global developmental delay; movement disorder; involuntary movements of upper extremities noted at 8 months; seizures - mild myoclonic seizures with head and body flexion occurred and evolved to single, symmetric spasms with bilateral arm extension shortly after 8 months; abnormal sleep patterns characterized by paucity of deep sleep and frequent awakenings; alacrima (abnormal tear production); unilateral ptosis; recurrent episodes of keratoconjunctivitis and poor lid closure during sleep; corneal ulcerations/scarring; chalazions; strabismus; decreased deep tendon reflexes; liver fibrosis; scoliosis; small hands and feet; donor subject learned to crawl and communicate with vocalizations; auditory brainstem response hearing abnormalities detected; electroencephalography (EEG) at 8 months showed generalized polyspike discharges; brain imaging (MRI) at various ages revealed: delayed myelination at 6 months, delayed myelination and supratentorial atrophy secondary to steroid therapy at 10 months, delayed myelination and recovery from supratentorial atrophy at 19 months; elevated blood lactate; elevated liver transaminases (three to four times upper limit of normal) noted in infancy; elevated alpha-fetoprotein; genetic testing revealed homozygous recessive nonsense mutation in NGLY1 gene: c.1201A>T (p.R401X) - found on both the maternal and paternal alleles by Sanger sequencing; management: physical therapy, occupational therapy, speech language therapy; medications: Lamictal, Depakote; epilepsy has been intractable despite many therapeutic trials; described as patient 4 by Enns et al 2014 (PMID 24651605); unaffected carrier mother is GM25348 (lymphoblast).

Characterizations

back to top
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by LINE assay
 
Gene NGLY1
Chromosomal Location 3p24.2
Allelic Variant 1 610661.0002; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
Identified Mutation ARG401TER; For discussion of the arg401-to-ter (R401X) mutation in the NGLY1 gene that was found in compound heterozygous state in a patient with congenital disorder of deglycosylation (CDDG; 615273) by Need et al. (2012), see 610661.0001.
 
Gene NGLY1
Chromosomal Location 3p24.2
Allelic Variant 2 610661.0002; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
Identified Mutation ARG401TER; For discussion of the arg401-to-ter (R401X) mutation in the NGLY1 gene that was found in compound heterozygous state in a patient with congenital disorder of deglycosylation (CDDG; 615273) by Need et al. (2012), see 610661.0001.

Phenotypic Data

back to top
Remarks Clinically affected; diagnosed by geneticist at 2 years of age; onset of symptoms at birth; delivered by Cesarean section at 38 weeks gestation when fetal distress was noted on cardiotocography; intrauterine growth restriction; neonatal jaundice; hypotonia; constipation in infancy; intermittent head flexion at 6 months; global developmental delay; movement disorder; involuntary movements of upper extremities noted at 8 months; seizures - mild myoclonic seizures with head and body flexion occurred and evolved to single, symmetric spasms with bilateral arm extension shortly after 8 months; abnormal sleep patterns characterized by paucity of deep sleep and frequent awakenings; alacrima (abnormal tear production); unilateral ptosis; recurrent episodes of keratoconjunctivitis and poor lid closure during sleep; corneal ulcerations/scarring; chalazions; strabismus; decreased deep tendon reflexes; liver fibrosis; scoliosis; small hands and feet; donor subject learned to crawl and communicate with vocalizations; auditory brainstem response hearing abnormalities detected; electroencephalography (EEG) at 8 months showed generalized polyspike discharges; brain imaging (MRI) at various ages revealed: delayed myelination at 6 months, delayed myelination and supratentorial atrophy secondary to steroid therapy at 10 months, delayed myelination and recovery from supratentorial atrophy at 19 months; elevated blood lactate; elevated liver transaminases (three to four times upper limit of normal) noted in infancy; elevated alpha-fetoprotein; genetic testing revealed homozygous recessive nonsense mutation in NGLY1 gene: c.1201A>T (p.R401X) - found on both the maternal and paternal alleles by Sanger sequencing; management: physical therapy, occupational therapy, speech language therapy; medications: Lamictal, Depakote; epilepsy has been intractable despite many therapeutic trials; described as patient 4 by Enns et al 2014 (PMID 24651605); unaffected carrier mother is GM25348 (lymphoblast).

Publications

back to top
Enns GM, Shashi V, Bainbridge M, Gambello MJ, Zahir FR, Bast T, Crimian R, Schoch K, Platt J, Cox R, Bernstein JA, Scavina M, Walter RS, Bibb A, Jones M, Hegde M, Graham BH, Need AC, Oviedo A, Schaaf CP, Boyle S, Butte AJ, Chen R, Clark MJ, Haraksingh R, Cowan TM, He P, Langlois S, Zoghbi HY, Snyder M, Gibbs RA, Freeze HH, Goldstein DB, Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway Genetics in medicine : official journal of the American College of Medical Genetics16:751-8 2013
PubMed ID: 24651605

External Links

back to top
Gene Cards NGLY1
NCBI GTR 610661 N-GLYCANASE 1; NGLY1
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
OMIM 610661 N-GLYCANASE 1; NGLY1
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG

Culture Protocols

back to top
Split Ratio 1:4
Temperature 37 C
Percent CO2 5%
Percent O2 AMBIENT
Medium Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not Inactivated
Substrate None specified
Subcultivation Method dilution - add fresh medium
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 3200
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube